Analyzing Kalaris Therapeutics Inc (KLRS)’s Gross, Operating, Pretax, and Net Margins
Kalaris Therapeutics Inc [KLRS] stock is trading at $4.66, up 1.97%. Until recently, the best way to gauge how the stock has performed was to look at its short-term value. The KLRS shares have gain 51.30% over the last week, with a monthly amount glided 82.75%, and seem to be holding up well over a […]